A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(85 sites)

United States

Pulmonary Associates, PA ( Site 1008), Phoenix, Arizona

University of California San Diego Health ( Site 1002), La Jolla, California

UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019), San Francisco, California

Jeffrey S. Sager, MD Medical Corporation ( Site 1060), Santa Barbara, California

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028), Torrance, California